Evidence map›Paper›PMID 40265007›Full record

ArticleFrontiers in oncology2025

Fusion feature-based hybrid methods for diagnosing oral squamous cell carcinoma in histopathological images.

Jiaxing Li

Abstract read
In one paragraph

Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Jiaxing LiBaoan Central Hospital of Shenzhen, Shenzhen, Guangdong, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: This study is experimental in nature and assesses the effectiveness of the Cross-Attention Vision Transformer (CrossViT) in the early detection of Oral Squamous Cell Carcinoma (OSCC) and proposes a hybrid model that combines CrossViT features with manually extracted features to improve the accuracy and robustness of OSCC diagnosis. Methods: We employed the CrossViT architecture, which utilizes a dual attention mechanism to process multi-scale features, in combination with Convolutional Neural Networks (CNN) technology for the effective analysis of image patches. Simultaneously, features were manually extracted by experts from OSCC pathological images and subsequently fused with the features extracted by CrossViT to enhance diagnostic performance. The classification task was performed using an Artificial Neural Networks (ANN) to further improve diagnostic accuracy. Model performance was evaluated based on classification accuracy on two independent OSCC datasets. Results: The proposed hybrid feature model demonstrated excellent performance in pathological diagnosis, achieving accuracies of 99.36% and 99.59%, respectively. Compared to CNN and Vision Transformer (ViT) models, the hybrid model was more effective in distinguishing between malignant and benign lesions, significantly improving diagnostic accuracy. Conclusion: By combining CrossViT with expert features, diagnostic accuracy for OSCC was significantly enhanced, thereby validating the potential of hybrid artificial intelligence models in clinical pathology. Future research will expand the dataset and explore the model's interpretability to facilitate its practical application in clinical settings.

Indexed as

artificial neural networksconvolutional neural networkscross-Attention vision transformeroral squamous cell carcinomavision transformer

Identifiers

PMID40265007
PMCPMC12011784

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.